Rochette L, Yao-Kouame J, Bralet J, Opie L H
Laboratoire de Pharmacodynamie et Physiologie Pharmaceutique, Université de Dijon, France.
Fundam Clin Pharmacol. 1988;2(5):385-97. doi: 10.1111/j.1472-8206.1988.tb01004.x.
The effects of the H1-receptor antagonists promethazine, mepyramine, and chlorpheniramine on ischemic and reperfusion arrhythmias were studied in the isolated perfused rat heart. Promethazine reduced both ischemic and reperfusion arrhythmias (2 x 10(-6)M-7.5 x 10(-6)M). Mepyramine and chlorpheniramine decreased these arrhythmias but at concentrations about 10 times higher. The H2-blockers cimetidine and ranitidine had no antiarrhythmic effect. Promethazine also: (i) increased release of noradrenaline by the heart; and (ii) increased coronary flow in the reperfusion period and in some mildly ischemic zones. It is proposed that promethazine exerts most of its antiarrhythmic effects by a nonspecific mechanism, possibly membrane stabilization; in addition, enhanced coronary flow may play a role.
在离体灌注大鼠心脏中研究了H1受体拮抗剂异丙嗪、美吡拉敏和氯苯那敏对缺血性和再灌注性心律失常的影响。异丙嗪可减少缺血性和再灌注性心律失常(2×10⁻⁶M - 7.5×10⁻⁶M)。美吡拉敏和氯苯那敏可减少这些心律失常,但所需浓度约高10倍。H2受体阻滞剂西咪替丁和雷尼替丁没有抗心律失常作用。异丙嗪还:(i)增加心脏去甲肾上腺素的释放;(ii)在再灌注期以及一些轻度缺血区域增加冠脉血流量。有人提出,异丙嗪主要通过非特异性机制发挥其抗心律失常作用,可能是膜稳定作用;此外,冠脉血流量增加可能也起一定作用。